Skip to main content
Clinical Trials/NCT02057822
NCT02057822
Unknown
Not Applicable

Cytokine Assay in Tears of Healthy Children and With Vernal Keratocunjonctivitis: Case Control Study and Monitoring of Cases at 6 Months

University Hospital, Clermont-Ferrand1 site in 1 country60 target enrollmentNovember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vernal Keratoconjunctivitis
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
60
Locations
1
Primary Endpoint
Concentration of 40 cytokines in tears
Last Updated
12 years ago

Overview

Brief Summary

The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.

Detailed Description

The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
January 2016
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Childrens between 3 and 18 years
  • Affiliated at system of French social security
  • Signed by the holders of parental authority of the sheet and written consent to participate in this study
  • First consultation at Clermont-Ferrand Hospital for vernal keratocunjunctivitis

Exclusion Criteria

  • Subject suffering from acute or chronic eye disease in which the physician investigator resound with the results: uveitis, glaucoma, retinopathy
  • Subject who had undergone eye surgery
  • Subject having an infection the day of collection: ENT, digestive, urinary
  • Subject with cancer, mental illness or any other condition in which the physician investigator sound informed consent and / or the results
  • Pregnant subject
  • Subject with contact lenses
  • Subject who judged by the investigating physician not enough cooperating to allow a safe collection

Outcomes

Primary Outcomes

Concentration of 40 cytokines in tears

Time Frame: at time 0

Comparaison of concentration of 40 cytokines in tears between healthy children and children with vernal keratoconjunctivitis

Secondary Outcomes

  • Modification of the inflammatory profile according to the clinical severity and treatment(at 6 month)
  • Validation of normal range of cytokines in tears of healthy children(at 6 month)

Study Sites (1)

Loading locations...

Similar Trials